nodes	percent_of_prediction	percent_of_DWPC	metapath
Ixabepilone—breast cancer—bone cancer	0.44	1	CtDrD
Ixabepilone—TUBB4B—bone cancer	0.231	0.516	CbGaD
Ixabepilone—TUBB2A—bone cancer	0.191	0.428	CbGaD
Ixabepilone—CYP3A4—bone cancer	0.025	0.056	CbGaD
Ixabepilone—TUBB2B—Post-chaperonin tubulin folding pathway—TUBB4B—bone cancer	0.00106	0.0147	CbGpPWpGaD
Ixabepilone—TUBB6—Post-chaperonin tubulin folding pathway—TUBB4B—bone cancer	0.00106	0.0147	CbGpPWpGaD
Ixabepilone—TUBB2A—Signaling events mediated by HDAC Class II—BCOR—bone cancer	0.00104	0.0144	CbGpPWpGaD
Ixabepilone—TUBB3—Post-chaperonin tubulin folding pathway—TUBB4B—bone cancer	0.00103	0.0142	CbGpPWpGaD
Ixabepilone—TUBB2A—Post-chaperonin tubulin folding pathway—TUBB4B—bone cancer	0.000995	0.0138	CbGpPWpGaD
Ixabepilone—TUBB6—Formation of tubulin folding intermediates by CCT/TriC—TUBB4B—bone cancer	0.000982	0.0136	CbGpPWpGaD
Ixabepilone—TUBB2B—Formation of tubulin folding intermediates by CCT/TriC—TUBB4B—bone cancer	0.000982	0.0136	CbGpPWpGaD
Ixabepilone—TUBB1—Post-chaperonin tubulin folding pathway—TUBB4B—bone cancer	0.000973	0.0135	CbGpPWpGaD
Ixabepilone—TUBB3—Formation of tubulin folding intermediates by CCT/TriC—TUBB4B—bone cancer	0.000948	0.0131	CbGpPWpGaD
Ixabepilone—TUBB2A—Formation of tubulin folding intermediates by CCT/TriC—TUBB4B—bone cancer	0.000919	0.0127	CbGpPWpGaD
Ixabepilone—TUBB6—Post-chaperonin tubulin folding pathway—TUBB2A—bone cancer	0.000918	0.0127	CbGpPWpGaD
Ixabepilone—TUBB2B—Post-chaperonin tubulin folding pathway—TUBB2A—bone cancer	0.000918	0.0127	CbGpPWpGaD
Ixabepilone—TUBB8—Pathogenic Escherichia coli infection—TUBB4B—bone cancer	0.000899	0.0124	CbGpPWpGaD
Ixabepilone—TUBB1—Formation of tubulin folding intermediates by CCT/TriC—TUBB4B—bone cancer	0.000898	0.0124	CbGpPWpGaD
Ixabepilone—TUBB3—Post-chaperonin tubulin folding pathway—TUBB2A—bone cancer	0.000887	0.0123	CbGpPWpGaD
Ixabepilone—TUBB4A—Post-chaperonin tubulin folding pathway—TUBB4B—bone cancer	0.000874	0.0121	CbGpPWpGaD
Ixabepilone—TUBB6—Formation of tubulin folding intermediates by CCT/TriC—TUBB2A—bone cancer	0.000848	0.0117	CbGpPWpGaD
Ixabepilone—TUBB2B—Formation of tubulin folding intermediates by CCT/TriC—TUBB2A—bone cancer	0.000848	0.0117	CbGpPWpGaD
Ixabepilone—TUBB1—Post-chaperonin tubulin folding pathway—TUBB2A—bone cancer	0.00084	0.0116	CbGpPWpGaD
Ixabepilone—TUBB3—Formation of tubulin folding intermediates by CCT/TriC—TUBB2A—bone cancer	0.000819	0.0113	CbGpPWpGaD
Ixabepilone—TUBB4A—Formation of tubulin folding intermediates by CCT/TriC—TUBB4B—bone cancer	0.000806	0.0112	CbGpPWpGaD
Ixabepilone—TUBB2B—Prefoldin mediated transfer of substrate to CCT/TriC—TUBB4B—bone cancer	0.000803	0.0111	CbGpPWpGaD
Ixabepilone—TUBB6—Prefoldin mediated transfer of substrate to CCT/TriC—TUBB4B—bone cancer	0.000803	0.0111	CbGpPWpGaD
Ixabepilone—TUBB6—Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding—TUBB4B—bone cancer	0.00078	0.0108	CbGpPWpGaD
Ixabepilone—TUBB2B—Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding—TUBB4B—bone cancer	0.00078	0.0108	CbGpPWpGaD
Ixabepilone—TUBB8—Pathogenic Escherichia coli infection—TUBB2A—bone cancer	0.000776	0.0107	CbGpPWpGaD
Ixabepilone—TUBB3—Prefoldin mediated transfer of substrate to CCT/TriC—TUBB4B—bone cancer	0.000776	0.0107	CbGpPWpGaD
Ixabepilone—TUBB1—Formation of tubulin folding intermediates by CCT/TriC—TUBB2A—bone cancer	0.000775	0.0107	CbGpPWpGaD
Ixabepilone—TUBB4A—Post-chaperonin tubulin folding pathway—TUBB2A—bone cancer	0.000754	0.0104	CbGpPWpGaD
Ixabepilone—TUBB3—Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding—TUBB4B—bone cancer	0.000753	0.0104	CbGpPWpGaD
Ixabepilone—TUBB2A—Prefoldin mediated transfer of substrate to CCT/TriC—TUBB4B—bone cancer	0.000751	0.0104	CbGpPWpGaD
Ixabepilone—TUBB8—Parkin-Ubiquitin Proteasomal System pathway—TUBB4B—bone cancer	0.000741	0.0103	CbGpPWpGaD
Ixabepilone—TUBB1—Prefoldin mediated transfer of substrate to CCT/TriC—TUBB4B—bone cancer	0.000735	0.0102	CbGpPWpGaD
Ixabepilone—TUBB2A—Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding—TUBB4B—bone cancer	0.00073	0.0101	CbGpPWpGaD
Ixabepilone—TUBB1—Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding—TUBB4B—bone cancer	0.000714	0.00987	CbGpPWpGaD
Ixabepilone—TUBB4A—Formation of tubulin folding intermediates by CCT/TriC—TUBB2A—bone cancer	0.000696	0.00963	CbGpPWpGaD
Ixabepilone—TUBB6—Prefoldin mediated transfer of substrate to CCT/TriC—TUBB2A—bone cancer	0.000693	0.00959	CbGpPWpGaD
Ixabepilone—TUBB2B—Prefoldin mediated transfer of substrate to CCT/TriC—TUBB2A—bone cancer	0.000693	0.00959	CbGpPWpGaD
Ixabepilone—TUBB4B—Post-chaperonin tubulin folding pathway—TUBB2A—bone cancer	0.00069	0.00954	CbGpPWpGaD
Ixabepilone—TUBB6—Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding—TUBB2A—bone cancer	0.000673	0.00931	CbGpPWpGaD
Ixabepilone—TUBB2B—Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding—TUBB2A—bone cancer	0.000673	0.00931	CbGpPWpGaD
Ixabepilone—TUBB3—Prefoldin mediated transfer of substrate to CCT/TriC—TUBB2A—bone cancer	0.00067	0.00926	CbGpPWpGaD
Ixabepilone—TUBB4A—Prefoldin mediated transfer of substrate to CCT/TriC—TUBB4B—bone cancer	0.00066	0.00912	CbGpPWpGaD
Ixabepilone—TUBB3—Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding—TUBB2A—bone cancer	0.00065	0.009	CbGpPWpGaD
Ixabepilone—TUBB4A—Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding—TUBB4B—bone cancer	0.000641	0.00886	CbGpPWpGaD
Ixabepilone—TUBB8—Parkin-Ubiquitin Proteasomal System pathway—TUBB2A—bone cancer	0.00064	0.00885	CbGpPWpGaD
Ixabepilone—TUBB4B—Formation of tubulin folding intermediates by CCT/TriC—TUBB2A—bone cancer	0.000637	0.00881	CbGpPWpGaD
Ixabepilone—TUBB1—Prefoldin mediated transfer of substrate to CCT/TriC—TUBB2A—bone cancer	0.000634	0.00877	CbGpPWpGaD
Ixabepilone—TUBB1—Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding—TUBB2A—bone cancer	0.000616	0.00852	CbGpPWpGaD
Ixabepilone—TUBB4A—Prefoldin mediated transfer of substrate to CCT/TriC—TUBB2A—bone cancer	0.000569	0.00787	CbGpPWpGaD
Ixabepilone—TUBB4A—Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding—TUBB2A—bone cancer	0.000553	0.00765	CbGpPWpGaD
Ixabepilone—TUBB4B—Prefoldin mediated transfer of substrate to CCT/TriC—TUBB2A—bone cancer	0.000521	0.0072	CbGpPWpGaD
Ixabepilone—TUBB4B—Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding—TUBB2A—bone cancer	0.000506	0.007	CbGpPWpGaD
Ixabepilone—TUBB2B—Chaperonin-mediated protein folding—TUBB4B—bone cancer	0.000499	0.0069	CbGpPWpGaD
Ixabepilone—TUBB6—Chaperonin-mediated protein folding—TUBB4B—bone cancer	0.000499	0.0069	CbGpPWpGaD
Ixabepilone—TUBB3—Chaperonin-mediated protein folding—TUBB4B—bone cancer	0.000482	0.00666	CbGpPWpGaD
Ixabepilone—TUBB2A—Chaperonin-mediated protein folding—TUBB4B—bone cancer	0.000466	0.00645	CbGpPWpGaD
Ixabepilone—TUBB1—Chaperonin-mediated protein folding—TUBB4B—bone cancer	0.000456	0.00631	CbGpPWpGaD
Ixabepilone—TUBB2B—Pathogenic Escherichia coli infection—TUBB4B—bone cancer	0.000455	0.00629	CbGpPWpGaD
Ixabepilone—TUBB6—Pathogenic Escherichia coli infection—TUBB4B—bone cancer	0.000455	0.00629	CbGpPWpGaD
Ixabepilone—TUBB2B—Protein folding—TUBB4B—bone cancer	0.000455	0.00629	CbGpPWpGaD
Ixabepilone—TUBB6—Protein folding—TUBB4B—bone cancer	0.000455	0.00629	CbGpPWpGaD
Ixabepilone—TUBB—Pathogenic Escherichia coli infection—TUBB4B—bone cancer	0.000451	0.00623	CbGpPWpGaD
Ixabepilone—TUBB3—Pathogenic Escherichia coli infection—TUBB4B—bone cancer	0.000439	0.00607	CbGpPWpGaD
Ixabepilone—TUBB3—Protein folding—TUBB4B—bone cancer	0.000439	0.00607	CbGpPWpGaD
Ixabepilone—TUBB2B—Chaperonin-mediated protein folding—TUBB2A—bone cancer	0.00043	0.00595	CbGpPWpGaD
Ixabepilone—TUBB6—Chaperonin-mediated protein folding—TUBB2A—bone cancer	0.00043	0.00595	CbGpPWpGaD
Ixabepilone—TUBB2A—Protein folding—TUBB4B—bone cancer	0.000425	0.00588	CbGpPWpGaD
Ixabepilone—TUBB2A—Pathogenic Escherichia coli infection—TUBB4B—bone cancer	0.000425	0.00588	CbGpPWpGaD
Ixabepilone—TUBB1—Protein folding—TUBB4B—bone cancer	0.000416	0.00575	CbGpPWpGaD
Ixabepilone—TUBB1—Pathogenic Escherichia coli infection—TUBB4B—bone cancer	0.000416	0.00575	CbGpPWpGaD
Ixabepilone—TUBB3—Chaperonin-mediated protein folding—TUBB2A—bone cancer	0.000416	0.00575	CbGpPWpGaD
Ixabepilone—TUBB—Loss of Nlp from mitotic centrosomes—TUBB4B—bone cancer	0.000415	0.00574	CbGpPWpGaD
Ixabepilone—TUBB4A—Chaperonin-mediated protein folding—TUBB4B—bone cancer	0.000409	0.00566	CbGpPWpGaD
Ixabepilone—TUBB1—Chaperonin-mediated protein folding—TUBB2A—bone cancer	0.000394	0.00544	CbGpPWpGaD
Ixabepilone—TUBB6—Protein folding—TUBB2A—bone cancer	0.000392	0.00543	CbGpPWpGaD
Ixabepilone—TUBB2B—Protein folding—TUBB2A—bone cancer	0.000392	0.00543	CbGpPWpGaD
Ixabepilone—TUBB6—Pathogenic Escherichia coli infection—TUBB2A—bone cancer	0.000392	0.00543	CbGpPWpGaD
Ixabepilone—TUBB2B—Pathogenic Escherichia coli infection—TUBB2A—bone cancer	0.000392	0.00543	CbGpPWpGaD
Ixabepilone—TUBB—Pathogenic Escherichia coli infection—TUBB2A—bone cancer	0.000389	0.00538	CbGpPWpGaD
Ixabepilone—TUBB3—Protein folding—TUBB2A—bone cancer	0.000379	0.00524	CbGpPWpGaD
Ixabepilone—TUBB3—Pathogenic Escherichia coli infection—TUBB2A—bone cancer	0.000379	0.00524	CbGpPWpGaD
Ixabepilone—TUBB2B—Parkin-Ubiquitin Proteasomal System pathway—TUBB4B—bone cancer	0.000375	0.00518	CbGpPWpGaD
Ixabepilone—TUBB6—Parkin-Ubiquitin Proteasomal System pathway—TUBB4B—bone cancer	0.000375	0.00518	CbGpPWpGaD
Ixabepilone—TUBB4A—Pathogenic Escherichia coli infection—TUBB4B—bone cancer	0.000373	0.00516	CbGpPWpGaD
Ixabepilone—TUBB4A—Protein folding—TUBB4B—bone cancer	0.000373	0.00516	CbGpPWpGaD
Ixabepilone—TUBB—Parkin-Ubiquitin Proteasomal System pathway—TUBB4B—bone cancer	0.000371	0.00514	CbGpPWpGaD
Ixabepilone—TUBB—Centrosome maturation—TUBB4B—bone cancer	0.000367	0.00508	CbGpPWpGaD
Ixabepilone—TUBB3—Parkin-Ubiquitin Proteasomal System pathway—TUBB4B—bone cancer	0.000362	0.00501	CbGpPWpGaD
Ixabepilone—TUBB1—Protein folding—TUBB2A—bone cancer	0.000359	0.00496	CbGpPWpGaD
Ixabepilone—TUBB1—Pathogenic Escherichia coli infection—TUBB2A—bone cancer	0.000359	0.00496	CbGpPWpGaD
Ixabepilone—TUBB4A—Chaperonin-mediated protein folding—TUBB2A—bone cancer	0.000353	0.00489	CbGpPWpGaD
Ixabepilone—TUBB2A—Parkin-Ubiquitin Proteasomal System pathway—TUBB4B—bone cancer	0.000351	0.00485	CbGpPWpGaD
Ixabepilone—TUBB4A—Loss of Nlp from mitotic centrosomes—TUBB4B—bone cancer	0.000344	0.00475	CbGpPWpGaD
Ixabepilone—TUBB1—Parkin-Ubiquitin Proteasomal System pathway—TUBB4B—bone cancer	0.000343	0.00474	CbGpPWpGaD
Ixabepilone—TUBB—Regulation of PLK1 Activity at G2/M Transition—TUBB4B—bone cancer	0.000337	0.00466	CbGpPWpGaD
Ixabepilone—TUBB2B—Parkin-Ubiquitin Proteasomal System pathway—TUBB2A—bone cancer	0.000324	0.00447	CbGpPWpGaD
Ixabepilone—TUBB6—Parkin-Ubiquitin Proteasomal System pathway—TUBB2A—bone cancer	0.000324	0.00447	CbGpPWpGaD
Ixabepilone—TUBB4B—Chaperonin-mediated protein folding—TUBB2A—bone cancer	0.000323	0.00447	CbGpPWpGaD
Ixabepilone—TUBB4A—Protein folding—TUBB2A—bone cancer	0.000322	0.00446	CbGpPWpGaD
Ixabepilone—TUBB4A—Pathogenic Escherichia coli infection—TUBB2A—bone cancer	0.000322	0.00446	CbGpPWpGaD
Ixabepilone—TUBB—Parkin-Ubiquitin Proteasomal System pathway—TUBB2A—bone cancer	0.000321	0.00443	CbGpPWpGaD
Ixabepilone—TUBB3—Parkin-Ubiquitin Proteasomal System pathway—TUBB2A—bone cancer	0.000312	0.00432	CbGpPWpGaD
Ixabepilone—TUBB4A—Parkin-Ubiquitin Proteasomal System pathway—TUBB4B—bone cancer	0.000308	0.00426	CbGpPWpGaD
Ixabepilone—TUBB4A—Centrosome maturation—TUBB4B—bone cancer	0.000304	0.00421	CbGpPWpGaD
Ixabepilone—TUBB1—Parkin-Ubiquitin Proteasomal System pathway—TUBB2A—bone cancer	0.000296	0.00409	CbGpPWpGaD
Ixabepilone—TUBB4B—Protein folding—TUBB2A—bone cancer	0.000295	0.00408	CbGpPWpGaD
Ixabepilone—TUBB4B—Pathogenic Escherichia coli infection—TUBB2A—bone cancer	0.000295	0.00408	CbGpPWpGaD
Ixabepilone—TUBB4A—Regulation of PLK1 Activity at G2/M Transition—TUBB4B—bone cancer	0.000279	0.00386	CbGpPWpGaD
Ixabepilone—TUBB2B—Orphan transporters—TUBB4B—bone cancer	0.000273	0.00378	CbGpPWpGaD
Ixabepilone—TUBB6—Orphan transporters—TUBB4B—bone cancer	0.000273	0.00378	CbGpPWpGaD
Ixabepilone—TUBB4A—Parkin-Ubiquitin Proteasomal System pathway—TUBB2A—bone cancer	0.000266	0.00367	CbGpPWpGaD
Ixabepilone—TUBB3—Orphan transporters—TUBB4B—bone cancer	0.000264	0.00365	CbGpPWpGaD
Ixabepilone—TUBB2A—Orphan transporters—TUBB4B—bone cancer	0.000255	0.00353	CbGpPWpGaD
Ixabepilone—TUBB—G2/M Transition—TUBB4B—bone cancer	0.000253	0.0035	CbGpPWpGaD
Ixabepilone—TUBB1—Orphan transporters—TUBB4B—bone cancer	0.00025	0.00345	CbGpPWpGaD
Ixabepilone—TUBB—Mitotic G2-G2/M phases—TUBB4B—bone cancer	0.00025	0.00345	CbGpPWpGaD
Ixabepilone—TUBB4B—Parkin-Ubiquitin Proteasomal System pathway—TUBB2A—bone cancer	0.000243	0.00336	CbGpPWpGaD
Ixabepilone—TUBB2B—Orphan transporters—TUBB2A—bone cancer	0.000236	0.00326	CbGpPWpGaD
Ixabepilone—TUBB6—Orphan transporters—TUBB2A—bone cancer	0.000236	0.00326	CbGpPWpGaD
Ixabepilone—TUBB3—Orphan transporters—TUBB2A—bone cancer	0.000228	0.00315	CbGpPWpGaD
Ixabepilone—TUBB4A—Orphan transporters—TUBB4B—bone cancer	0.000224	0.0031	CbGpPWpGaD
Ixabepilone—TUBB1—Orphan transporters—TUBB2A—bone cancer	0.000216	0.00298	CbGpPWpGaD
Ixabepilone—TUBB4A—G2/M Transition—TUBB4B—bone cancer	0.00021	0.0029	CbGpPWpGaD
Ixabepilone—TUBB4A—Mitotic G2-G2/M phases—TUBB4B—bone cancer	0.000207	0.00286	CbGpPWpGaD
Ixabepilone—TUBB3—Diurnally Regulated Genes with Circadian Orthologs—GSTP1—bone cancer	0.000199	0.00276	CbGpPWpGaD
Ixabepilone—TUBB4A—Orphan transporters—TUBB2A—bone cancer	0.000194	0.00268	CbGpPWpGaD
Ixabepilone—TUBB4B—Orphan transporters—TUBB2A—bone cancer	0.000177	0.00245	CbGpPWpGaD
Ixabepilone—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000142	0.00196	CbGpPWpGaD
Ixabepilone—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000133	0.00184	CbGpPWpGaD
Ixabepilone—Neuropathy—Doxorubicin—bone cancer	0.00012	0.00295	CcSEcCtD
Ixabepilone—Sepsis—Epirubicin—bone cancer	0.00012	0.00295	CcSEcCtD
Ixabepilone—Alopecia—Cisplatin—bone cancer	0.000119	0.00293	CcSEcCtD
Ixabepilone—Malnutrition—Cisplatin—bone cancer	0.000117	0.00289	CcSEcCtD
Ixabepilone—Oesophagitis—Doxorubicin—bone cancer	0.000117	0.00287	CcSEcCtD
Ixabepilone—Muscle spasms—Cisplatin—bone cancer	0.000113	0.00278	CcSEcCtD
Ixabepilone—Sepsis—Doxorubicin—bone cancer	0.000111	0.00273	CcSEcCtD
Ixabepilone—TUBB6—Metabolism of proteins—MOGS—bone cancer	0.000111	0.00153	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—MOGS—bone cancer	0.000111	0.00153	CbGpPWpGaD
Ixabepilone—Lethargy—Methotrexate—bone cancer	0.000109	0.00269	CcSEcCtD
Ixabepilone—Anaemia—Cisplatin—bone cancer	0.000109	0.00267	CcSEcCtD
Ixabepilone—Hot flush—Epirubicin—bone cancer	0.000107	0.00263	CcSEcCtD
Ixabepilone—TUBB3—Metabolism of proteins—MOGS—bone cancer	0.000107	0.00148	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—ZW10—bone cancer	0.000106	0.00147	CbGpPWpGaD
Ixabepilone—Menopausal symptoms—Epirubicin—bone cancer	0.000106	0.00261	CcSEcCtD
Ixabepilone—Leukopenia—Cisplatin—bone cancer	0.000105	0.00259	CcSEcCtD
Ixabepilone—TUBB2A—Metabolism of proteins—MOGS—bone cancer	0.000103	0.00143	CbGpPWpGaD
Ixabepilone—Lethargy—Epirubicin—bone cancer	0.000102	0.00251	CcSEcCtD
Ixabepilone—TUBB1—Metabolism of proteins—MOGS—bone cancer	0.000101	0.0014	CbGpPWpGaD
Ixabepilone—Hyponatraemia—Epirubicin—bone cancer	0.000101	0.00247	CcSEcCtD
Ixabepilone—Gastrointestinal haemorrhage—Epirubicin—bone cancer	0.0001	0.00246	CcSEcCtD
Ixabepilone—Myalgia—Cisplatin—bone cancer	0.0001	0.00246	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	9.93e-05	0.00244	CcSEcCtD
Ixabepilone—Hot flush—Doxorubicin—bone cancer	9.91e-05	0.00244	CcSEcCtD
Ixabepilone—Menopausal symptoms—Doxorubicin—bone cancer	9.82e-05	0.00242	CcSEcCtD
Ixabepilone—Oedema—Cisplatin—bone cancer	9.59e-05	0.00236	CcSEcCtD
Ixabepilone—Infection—Cisplatin—bone cancer	9.53e-05	0.00234	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—ZW10—bone cancer	9.5e-05	0.00131	CbGpPWpGaD
Ixabepilone—Lethargy—Doxorubicin—bone cancer	9.46e-05	0.00233	CcSEcCtD
Ixabepilone—Nervous system disorder—Cisplatin—bone cancer	9.4e-05	0.00231	CcSEcCtD
Ixabepilone—Thrombocytopenia—Cisplatin—bone cancer	9.39e-05	0.00231	CcSEcCtD
Ixabepilone—Dehydration—Epirubicin—bone cancer	9.32e-05	0.00229	CcSEcCtD
Ixabepilone—Skin disorder—Cisplatin—bone cancer	9.31e-05	0.00229	CcSEcCtD
Ixabepilone—Hyponatraemia—Doxorubicin—bone cancer	9.31e-05	0.00229	CcSEcCtD
Ixabepilone—Gastrointestinal haemorrhage—Doxorubicin—bone cancer	9.27e-05	0.00228	CcSEcCtD
Ixabepilone—Anorexia—Cisplatin—bone cancer	9.14e-05	0.00225	CcSEcCtD
Ixabepilone—Hypokalaemia—Epirubicin—bone cancer	9.12e-05	0.00224	CcSEcCtD
Ixabepilone—TUBB4A—Metabolism of proteins—MOGS—bone cancer	9.08e-05	0.00126	CbGpPWpGaD
Ixabepilone—Hypotension—Cisplatin—bone cancer	8.96e-05	0.0022	CcSEcCtD
Ixabepilone—Gastritis—Epirubicin—bone cancer	8.87e-05	0.00218	CcSEcCtD
Ixabepilone—Muscular weakness—Epirubicin—bone cancer	8.84e-05	0.00217	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—ZW10—bone cancer	8.81e-05	0.00122	CbGpPWpGaD
Ixabepilone—Pancytopenia—Methotrexate—bone cancer	8.79e-05	0.00216	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Cisplatin—bone cancer	8.74e-05	0.00215	CcSEcCtD
Ixabepilone—Dysphagia—Epirubicin—bone cancer	8.66e-05	0.00213	CcSEcCtD
Ixabepilone—Neutropenia—Methotrexate—bone cancer	8.65e-05	0.00213	CcSEcCtD
Ixabepilone—Dehydration—Doxorubicin—bone cancer	8.62e-05	0.00212	CcSEcCtD
Ixabepilone—Paraesthesia—Cisplatin—bone cancer	8.61e-05	0.00212	CcSEcCtD
Ixabepilone—Upper respiratory tract infection—Methotrexate—bone cancer	8.6e-05	0.00211	CcSEcCtD
Ixabepilone—Dyspnoea—Cisplatin—bone cancer	8.55e-05	0.0021	CcSEcCtD
Ixabepilone—Hypokalaemia—Doxorubicin—bone cancer	8.44e-05	0.00207	CcSEcCtD
Ixabepilone—Angina pectoris—Epirubicin—bone cancer	8.43e-05	0.00207	CcSEcCtD
Ixabepilone—Decreased appetite—Cisplatin—bone cancer	8.33e-05	0.00205	CcSEcCtD
Ixabepilone—TUBB4B—Metabolism of proteins—MOGS—bone cancer	8.3e-05	0.00115	CbGpPWpGaD
Ixabepilone—Pneumonia—Methotrexate—bone cancer	8.3e-05	0.00204	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Cisplatin—bone cancer	8.28e-05	0.00204	CcSEcCtD
Ixabepilone—Infestation—Methotrexate—bone cancer	8.25e-05	0.00203	CcSEcCtD
Ixabepilone—Infestation NOS—Methotrexate—bone cancer	8.25e-05	0.00203	CcSEcCtD
Ixabepilone—Pancytopenia—Epirubicin—bone cancer	8.22e-05	0.00202	CcSEcCtD
Ixabepilone—Gastritis—Doxorubicin—bone cancer	8.2e-05	0.00202	CcSEcCtD
Ixabepilone—Pain—Cisplatin—bone cancer	8.2e-05	0.00202	CcSEcCtD
Ixabepilone—Muscular weakness—Doxorubicin—bone cancer	8.18e-05	0.00201	CcSEcCtD
Ixabepilone—Renal failure—Methotrexate—bone cancer	8.11e-05	0.00199	CcSEcCtD
Ixabepilone—Neutropenia—Epirubicin—bone cancer	8.1e-05	0.00199	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—ZW10—bone cancer	8.06e-05	0.00111	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—TUBB4B—bone cancer	8.06e-05	0.00111	CbGpPWpGaD
Ixabepilone—Upper respiratory tract infection—Epirubicin—bone cancer	8.05e-05	0.00198	CcSEcCtD
Ixabepilone—Stomatitis—Methotrexate—bone cancer	8.04e-05	0.00198	CcSEcCtD
Ixabepilone—Dysphagia—Doxorubicin—bone cancer	8.01e-05	0.00197	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle—ZW10—bone cancer	7.88e-05	0.00109	CbGpPWpGaD
Ixabepilone—Weight decreased—Epirubicin—bone cancer	7.83e-05	0.00193	CcSEcCtD
Ixabepilone—Angina pectoris—Doxorubicin—bone cancer	7.8e-05	0.00192	CcSEcCtD
Ixabepilone—Hepatobiliary disease—Methotrexate—bone cancer	7.8e-05	0.00192	CcSEcCtD
Ixabepilone—Pneumonia—Epirubicin—bone cancer	7.77e-05	0.00191	CcSEcCtD
Ixabepilone—Infestation NOS—Epirubicin—bone cancer	7.72e-05	0.0019	CcSEcCtD
Ixabepilone—Infestation—Epirubicin—bone cancer	7.72e-05	0.0019	CcSEcCtD
Ixabepilone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	7.66e-05	0.00106	CbGpPWpGaD
Ixabepilone—Pancytopenia—Doxorubicin—bone cancer	7.61e-05	0.00187	CcSEcCtD
Ixabepilone—Renal failure—Epirubicin—bone cancer	7.59e-05	0.00187	CcSEcCtD
Ixabepilone—Body temperature increased—Cisplatin—bone cancer	7.58e-05	0.00186	CcSEcCtD
Ixabepilone—Neuropathy peripheral—Epirubicin—bone cancer	7.57e-05	0.00186	CcSEcCtD
Ixabepilone—Jaundice—Epirubicin—bone cancer	7.53e-05	0.00185	CcSEcCtD
Ixabepilone—Stomatitis—Epirubicin—bone cancer	7.53e-05	0.00185	CcSEcCtD
Ixabepilone—Urinary tract infection—Epirubicin—bone cancer	7.5e-05	0.00185	CcSEcCtD
Ixabepilone—Neutropenia—Doxorubicin—bone cancer	7.49e-05	0.00184	CcSEcCtD
Ixabepilone—Upper respiratory tract infection—Doxorubicin—bone cancer	7.45e-05	0.00183	CcSEcCtD
Ixabepilone—Haemoglobin—Methotrexate—bone cancer	7.44e-05	0.00183	CcSEcCtD
Ixabepilone—Haemorrhage—Methotrexate—bone cancer	7.41e-05	0.00182	CcSEcCtD
Ixabepilone—Urinary tract disorder—Methotrexate—bone cancer	7.31e-05	0.0018	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle, Mitotic—RFC1—bone cancer	7.3e-05	0.00101	CbGpPWpGaD
Ixabepilone—Hepatobiliary disease—Epirubicin—bone cancer	7.3e-05	0.0018	CcSEcCtD
Ixabepilone—Urethral disorder—Methotrexate—bone cancer	7.26e-05	0.00179	CcSEcCtD
Ixabepilone—Weight decreased—Doxorubicin—bone cancer	7.25e-05	0.00178	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—TUBB4B—bone cancer	7.2e-05	0.000996	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—ZW10—bone cancer	7.2e-05	0.000996	CbGpPWpGaD
Ixabepilone—Pneumonia—Doxorubicin—bone cancer	7.18e-05	0.00177	CcSEcCtD
Ixabepilone—Infestation NOS—Doxorubicin—bone cancer	7.14e-05	0.00176	CcSEcCtD
Ixabepilone—Infestation—Doxorubicin—bone cancer	7.14e-05	0.00176	CcSEcCtD
Ixabepilone—Hypersensitivity—Cisplatin—bone cancer	7.06e-05	0.00174	CcSEcCtD
Ixabepilone—TUBB2A—Signaling events mediated by HDAC Class III—TP53—bone cancer	7.03e-05	0.000972	CbGpPWpGaD
Ixabepilone—Renal failure—Doxorubicin—bone cancer	7.02e-05	0.00173	CcSEcCtD
Ixabepilone—Erythema multiforme—Methotrexate—bone cancer	7e-05	0.00172	CcSEcCtD
Ixabepilone—Neuropathy peripheral—Doxorubicin—bone cancer	7e-05	0.00172	CcSEcCtD
Ixabepilone—Haemoglobin—Epirubicin—bone cancer	6.97e-05	0.00171	CcSEcCtD
Ixabepilone—Jaundice—Doxorubicin—bone cancer	6.96e-05	0.00171	CcSEcCtD
Ixabepilone—Stomatitis—Doxorubicin—bone cancer	6.96e-05	0.00171	CcSEcCtD
Ixabepilone—Urinary tract infection—Doxorubicin—bone cancer	6.94e-05	0.00171	CcSEcCtD
Ixabepilone—Haemorrhage—Epirubicin—bone cancer	6.93e-05	0.0017	CcSEcCtD
Ixabepilone—Eye disorder—Methotrexate—bone cancer	6.92e-05	0.0017	CcSEcCtD
Ixabepilone—Hypoaesthesia—Epirubicin—bone cancer	6.9e-05	0.0017	CcSEcCtD
Ixabepilone—Asthenia—Cisplatin—bone cancer	6.88e-05	0.00169	CcSEcCtD
Ixabepilone—Cardiac disorder—Methotrexate—bone cancer	6.87e-05	0.00169	CcSEcCtD
Ixabepilone—Urinary tract disorder—Epirubicin—bone cancer	6.84e-05	0.00168	CcSEcCtD
Ixabepilone—Connective tissue disorder—Epirubicin—bone cancer	6.81e-05	0.00167	CcSEcCtD
Ixabepilone—Urethral disorder—Epirubicin—bone cancer	6.79e-05	0.00167	CcSEcCtD
Ixabepilone—Hepatobiliary disease—Doxorubicin—bone cancer	6.76e-05	0.00166	CcSEcCtD
Ixabepilone—Angiopathy—Methotrexate—bone cancer	6.72e-05	0.00165	CcSEcCtD
Ixabepilone—Immune system disorder—Methotrexate—bone cancer	6.69e-05	0.00164	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—TUBB4B—bone cancer	6.68e-05	0.000923	CbGpPWpGaD
Ixabepilone—Mediastinal disorder—Methotrexate—bone cancer	6.67e-05	0.00164	CcSEcCtD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—TUBB4B—bone cancer	6.67e-05	0.000922	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—TUBB4B—bone cancer	6.67e-05	0.000922	CbGpPWpGaD
Ixabepilone—Chills—Methotrexate—bone cancer	6.64e-05	0.00163	CcSEcCtD
Ixabepilone—Diarrhoea—Cisplatin—bone cancer	6.56e-05	0.00161	CcSEcCtD
Ixabepilone—Erythema multiforme—Epirubicin—bone cancer	6.55e-05	0.00161	CcSEcCtD
Ixabepilone—Alopecia—Methotrexate—bone cancer	6.54e-05	0.00161	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—RFC1—bone cancer	6.53e-05	0.000903	CbGpPWpGaD
Ixabepilone—Mental disorder—Methotrexate—bone cancer	6.49e-05	0.0016	CcSEcCtD
Ixabepilone—Eye disorder—Epirubicin—bone cancer	6.48e-05	0.00159	CcSEcCtD
Ixabepilone—Malnutrition—Methotrexate—bone cancer	6.45e-05	0.00159	CcSEcCtD
Ixabepilone—Haemoglobin—Doxorubicin—bone cancer	6.45e-05	0.00158	CcSEcCtD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—TUBB4B—bone cancer	6.44e-05	0.000891	CbGpPWpGaD
Ixabepilone—Cardiac disorder—Epirubicin—bone cancer	6.43e-05	0.00158	CcSEcCtD
Ixabepilone—Haemorrhage—Doxorubicin—bone cancer	6.41e-05	0.00158	CcSEcCtD
Ixabepilone—Hypoaesthesia—Doxorubicin—bone cancer	6.38e-05	0.00157	CcSEcCtD
Ixabepilone—Urinary tract disorder—Doxorubicin—bone cancer	6.33e-05	0.00156	CcSEcCtD
Ixabepilone—Connective tissue disorder—Doxorubicin—bone cancer	6.3e-05	0.00155	CcSEcCtD
Ixabepilone—Angiopathy—Epirubicin—bone cancer	6.29e-05	0.00155	CcSEcCtD
Ixabepilone—Urethral disorder—Doxorubicin—bone cancer	6.29e-05	0.00155	CcSEcCtD
Ixabepilone—Immune system disorder—Epirubicin—bone cancer	6.26e-05	0.00154	CcSEcCtD
Ixabepilone—Mediastinal disorder—Epirubicin—bone cancer	6.25e-05	0.00154	CcSEcCtD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—TUBB4B—bone cancer	6.24e-05	0.000862	CbGpPWpGaD
Ixabepilone—Chills—Epirubicin—bone cancer	6.22e-05	0.00153	CcSEcCtD
Ixabepilone—Alopecia—Epirubicin—bone cancer	6.12e-05	0.00151	CcSEcCtD
Ixabepilone—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	6.1e-05	0.000843	CbGpPWpGaD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	6.1e-05	0.000843	CbGpPWpGaD
Ixabepilone—Vomiting—Cisplatin—bone cancer	6.1e-05	0.0015	CcSEcCtD
Ixabepilone—Mental disorder—Epirubicin—bone cancer	6.07e-05	0.00149	CcSEcCtD
Ixabepilone—Erythema multiforme—Doxorubicin—bone cancer	6.06e-05	0.00149	CcSEcCtD
Ixabepilone—TUBB2B—Metabolism of proteins—TUBB4B—bone cancer	6.06e-05	0.000838	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—TUBB4B—bone cancer	6.06e-05	0.000838	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—RFC1—bone cancer	6.05e-05	0.000837	CbGpPWpGaD
Ixabepilone—Rash—Cisplatin—bone cancer	6.05e-05	0.00149	CcSEcCtD
Ixabepilone—Dermatitis—Cisplatin—bone cancer	6.04e-05	0.00149	CcSEcCtD
Ixabepilone—Malnutrition—Epirubicin—bone cancer	6.03e-05	0.00148	CcSEcCtD
Ixabepilone—Eye disorder—Doxorubicin—bone cancer	5.99e-05	0.00147	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle—TUBB4B—bone cancer	5.97e-05	0.000826	CbGpPWpGaD
Ixabepilone—Anaemia—Methotrexate—bone cancer	5.96e-05	0.00147	CcSEcCtD
Ixabepilone—Cardiac disorder—Doxorubicin—bone cancer	5.95e-05	0.00146	CcSEcCtD
Ixabepilone—TUBB3—Metabolism of proteins—TUBB4B—bone cancer	5.85e-05	0.000809	CbGpPWpGaD
Ixabepilone—Angiopathy—Doxorubicin—bone cancer	5.82e-05	0.00143	CcSEcCtD
Ixabepilone—Muscle spasms—Epirubicin—bone cancer	5.8e-05	0.00143	CcSEcCtD
Ixabepilone—Immune system disorder—Doxorubicin—bone cancer	5.79e-05	0.00142	CcSEcCtD
Ixabepilone—Mediastinal disorder—Doxorubicin—bone cancer	5.78e-05	0.00142	CcSEcCtD
Ixabepilone—Leukopenia—Methotrexate—bone cancer	5.77e-05	0.00142	CcSEcCtD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—TUBB2A—bone cancer	5.75e-05	0.000796	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—TUBB2A—bone cancer	5.75e-05	0.000796	CbGpPWpGaD
Ixabepilone—Chills—Doxorubicin—bone cancer	5.75e-05	0.00141	CcSEcCtD
Ixabepilone—Nausea—Cisplatin—bone cancer	5.7e-05	0.0014	CcSEcCtD
Ixabepilone—TUBB2A—Metabolism of proteins—TUBB4B—bone cancer	5.67e-05	0.000784	CbGpPWpGaD
Ixabepilone—Alopecia—Doxorubicin—bone cancer	5.67e-05	0.00139	CcSEcCtD
Ixabepilone—Cough—Methotrexate—bone cancer	5.63e-05	0.00138	CcSEcCtD
Ixabepilone—Mental disorder—Doxorubicin—bone cancer	5.62e-05	0.00138	CcSEcCtD
Ixabepilone—Malnutrition—Doxorubicin—bone cancer	5.58e-05	0.00137	CcSEcCtD
Ixabepilone—Anaemia—Epirubicin—bone cancer	5.58e-05	0.00137	CcSEcCtD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—TUBB2A—bone cancer	5.56e-05	0.000769	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—TUBB4B—bone cancer	5.54e-05	0.000766	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—RFC1—bone cancer	5.53e-05	0.000766	CbGpPWpGaD
Ixabepilone—Chest pain—Methotrexate—bone cancer	5.49e-05	0.00135	CcSEcCtD
Ixabepilone—Arthralgia—Methotrexate—bone cancer	5.49e-05	0.00135	CcSEcCtD
Ixabepilone—Myalgia—Methotrexate—bone cancer	5.49e-05	0.00135	CcSEcCtD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—TUBB4B—bone cancer	5.47e-05	0.000757	CbGpPWpGaD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	5.45e-05	0.00134	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle—RFC1—bone cancer	5.41e-05	0.000748	CbGpPWpGaD
Ixabepilone—Syncope—Epirubicin—bone cancer	5.41e-05	0.00133	CcSEcCtD
Ixabepilone—Leukopenia—Epirubicin—bone cancer	5.4e-05	0.00133	CcSEcCtD
Ixabepilone—Muscle spasms—Doxorubicin—bone cancer	5.37e-05	0.00132	CcSEcCtD
Ixabepilone—Loss of consciousness—Epirubicin—bone cancer	5.3e-05	0.0013	CcSEcCtD
Ixabepilone—Cough—Epirubicin—bone cancer	5.26e-05	0.00129	CcSEcCtD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	5.26e-05	0.000728	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—TUBB2A—bone cancer	5.23e-05	0.000723	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—TUBB2A—bone cancer	5.23e-05	0.000723	CbGpPWpGaD
Ixabepilone—Infection—Methotrexate—bone cancer	5.23e-05	0.00129	CcSEcCtD
Ixabepilone—Nervous system disorder—Methotrexate—bone cancer	5.16e-05	0.00127	CcSEcCtD
Ixabepilone—Anaemia—Doxorubicin—bone cancer	5.16e-05	0.00127	CcSEcCtD
Ixabepilone—Thrombocytopenia—Methotrexate—bone cancer	5.15e-05	0.00127	CcSEcCtD
Ixabepilone—Myalgia—Epirubicin—bone cancer	5.14e-05	0.00126	CcSEcCtD
Ixabepilone—Chest pain—Epirubicin—bone cancer	5.14e-05	0.00126	CcSEcCtD
Ixabepilone—Arthralgia—Epirubicin—bone cancer	5.14e-05	0.00126	CcSEcCtD
Ixabepilone—Skin disorder—Methotrexate—bone cancer	5.11e-05	0.00126	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	5.1e-05	0.00125	CcSEcCtD
Ixabepilone—TUBB3—Metabolism of proteins—TUBB2A—bone cancer	5.05e-05	0.000699	CbGpPWpGaD
Ixabepilone—Anorexia—Methotrexate—bone cancer	5.02e-05	0.00123	CcSEcCtD
Ixabepilone—Syncope—Doxorubicin—bone cancer	5.01e-05	0.00123	CcSEcCtD
Ixabepilone—Leukopenia—Doxorubicin—bone cancer	5e-05	0.00123	CcSEcCtD
Ixabepilone—TUBB4A—Metabolism of proteins—TUBB4B—bone cancer	4.98e-05	0.000688	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—RFC1—bone cancer	4.95e-05	0.000684	CbGpPWpGaD
Ixabepilone—Oedema—Epirubicin—bone cancer	4.92e-05	0.00121	CcSEcCtD
Ixabepilone—Hypotension—Methotrexate—bone cancer	4.92e-05	0.00121	CcSEcCtD
Ixabepilone—Loss of consciousness—Doxorubicin—bone cancer	4.91e-05	0.00121	CcSEcCtD
Ixabepilone—Infection—Epirubicin—bone cancer	4.89e-05	0.0012	CcSEcCtD
Ixabepilone—Cough—Doxorubicin—bone cancer	4.87e-05	0.0012	CcSEcCtD
Ixabepilone—Shock—Epirubicin—bone cancer	4.84e-05	0.00119	CcSEcCtD
Ixabepilone—Nervous system disorder—Epirubicin—bone cancer	4.83e-05	0.00119	CcSEcCtD
Ixabepilone—Thrombocytopenia—Epirubicin—bone cancer	4.82e-05	0.00119	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Methotrexate—bone cancer	4.79e-05	0.00118	CcSEcCtD
Ixabepilone—TUBB1—Metabolism of proteins—TUBB2A—bone cancer	4.78e-05	0.000662	CbGpPWpGaD
Ixabepilone—Skin disorder—Epirubicin—bone cancer	4.78e-05	0.00118	CcSEcCtD
Ixabepilone—Insomnia—Methotrexate—bone cancer	4.76e-05	0.00117	CcSEcCtD
Ixabepilone—Myalgia—Doxorubicin—bone cancer	4.75e-05	0.00117	CcSEcCtD
Ixabepilone—Arthralgia—Doxorubicin—bone cancer	4.75e-05	0.00117	CcSEcCtD
Ixabepilone—Chest pain—Doxorubicin—bone cancer	4.75e-05	0.00117	CcSEcCtD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—TUBB2A—bone cancer	4.73e-05	0.000654	CbGpPWpGaD
Ixabepilone—Paraesthesia—Methotrexate—bone cancer	4.72e-05	0.00116	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	4.72e-05	0.00116	CcSEcCtD
Ixabepilone—Anorexia—Epirubicin—bone cancer	4.69e-05	0.00115	CcSEcCtD
Ixabepilone—Dyspnoea—Methotrexate—bone cancer	4.69e-05	0.00115	CcSEcCtD
Ixabepilone—Hypotension—Epirubicin—bone cancer	4.6e-05	0.00113	CcSEcCtD
Ixabepilone—Decreased appetite—Methotrexate—bone cancer	4.57e-05	0.00112	CcSEcCtD
Ixabepilone—Oedema—Doxorubicin—bone cancer	4.56e-05	0.00112	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Methotrexate—bone cancer	4.54e-05	0.00112	CcSEcCtD
Ixabepilone—Fatigue—Methotrexate—bone cancer	4.54e-05	0.00112	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle, Mitotic—DHFR—bone cancer	4.53e-05	0.000626	CbGpPWpGaD
Ixabepilone—Infection—Doxorubicin—bone cancer	4.53e-05	0.00111	CcSEcCtD
Ixabepilone—Pain—Methotrexate—bone cancer	4.5e-05	0.00111	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Epirubicin—bone cancer	4.49e-05	0.0011	CcSEcCtD
Ixabepilone—Shock—Doxorubicin—bone cancer	4.48e-05	0.0011	CcSEcCtD
Ixabepilone—Nervous system disorder—Doxorubicin—bone cancer	4.47e-05	0.0011	CcSEcCtD
Ixabepilone—Thrombocytopenia—Doxorubicin—bone cancer	4.46e-05	0.0011	CcSEcCtD
Ixabepilone—Insomnia—Epirubicin—bone cancer	4.45e-05	0.0011	CcSEcCtD
Ixabepilone—Skin disorder—Doxorubicin—bone cancer	4.43e-05	0.00109	CcSEcCtD
Ixabepilone—Paraesthesia—Epirubicin—bone cancer	4.42e-05	0.00109	CcSEcCtD
Ixabepilone—Dyspnoea—Epirubicin—bone cancer	4.39e-05	0.00108	CcSEcCtD
Ixabepilone—Anorexia—Doxorubicin—bone cancer	4.34e-05	0.00107	CcSEcCtD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—TUBB2A—bone cancer	4.32e-05	0.000598	CbGpPWpGaD
Ixabepilone—Gastrointestinal pain—Methotrexate—bone cancer	4.3e-05	0.00106	CcSEcCtD
Ixabepilone—TUBB4A—Metabolism of proteins—TUBB2A—bone cancer	4.29e-05	0.000594	CbGpPWpGaD
Ixabepilone—Decreased appetite—Epirubicin—bone cancer	4.28e-05	0.00105	CcSEcCtD
Ixabepilone—Hypotension—Doxorubicin—bone cancer	4.26e-05	0.00105	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Epirubicin—bone cancer	4.25e-05	0.00105	CcSEcCtD
Ixabepilone—Fatigue—Epirubicin—bone cancer	4.25e-05	0.00104	CcSEcCtD
Ixabepilone—Pain—Epirubicin—bone cancer	4.21e-05	0.00104	CcSEcCtD
Ixabepilone—Constipation—Epirubicin—bone cancer	4.21e-05	0.00104	CcSEcCtD
Ixabepilone—Abdominal pain—Methotrexate—bone cancer	4.16e-05	0.00102	CcSEcCtD
Ixabepilone—Body temperature increased—Methotrexate—bone cancer	4.16e-05	0.00102	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Doxorubicin—bone cancer	4.15e-05	0.00102	CcSEcCtD
Ixabepilone—Insomnia—Doxorubicin—bone cancer	4.12e-05	0.00101	CcSEcCtD
Ixabepilone—Paraesthesia—Doxorubicin—bone cancer	4.09e-05	0.00101	CcSEcCtD
Ixabepilone—Dyspnoea—Doxorubicin—bone cancer	4.06e-05	0.000999	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—DHFR—bone cancer	4.05e-05	0.00056	CbGpPWpGaD
Ixabepilone—Gastrointestinal pain—Epirubicin—bone cancer	4.03e-05	0.00099	CcSEcCtD
Ixabepilone—Decreased appetite—Doxorubicin—bone cancer	3.96e-05	0.000974	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Doxorubicin—bone cancer	3.93e-05	0.000967	CcSEcCtD
Ixabepilone—TUBB4B—Metabolism of proteins—TUBB2A—bone cancer	3.93e-05	0.000543	CbGpPWpGaD
Ixabepilone—Fatigue—Doxorubicin—bone cancer	3.93e-05	0.000966	CcSEcCtD
Ixabepilone—Pain—Doxorubicin—bone cancer	3.9e-05	0.000958	CcSEcCtD
Ixabepilone—Constipation—Doxorubicin—bone cancer	3.9e-05	0.000958	CcSEcCtD
Ixabepilone—Abdominal pain—Epirubicin—bone cancer	3.89e-05	0.000957	CcSEcCtD
Ixabepilone—Body temperature increased—Epirubicin—bone cancer	3.89e-05	0.000957	CcSEcCtD
Ixabepilone—Hypersensitivity—Methotrexate—bone cancer	3.88e-05	0.000953	CcSEcCtD
Ixabepilone—Asthenia—Methotrexate—bone cancer	3.78e-05	0.000928	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—DHFR—bone cancer	3.75e-05	0.000519	CbGpPWpGaD
Ixabepilone—Gastrointestinal pain—Doxorubicin—bone cancer	3.73e-05	0.000916	CcSEcCtD
Ixabepilone—Pruritus—Methotrexate—bone cancer	3.72e-05	0.000915	CcSEcCtD
Ixabepilone—TUBB2B—Metabolism of proteins—EIF2S1—bone cancer	3.65e-05	0.000504	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—EIF2S1—bone cancer	3.65e-05	0.000504	CbGpPWpGaD
Ixabepilone—Hypersensitivity—Epirubicin—bone cancer	3.63e-05	0.000892	CcSEcCtD
Ixabepilone—Abdominal pain—Doxorubicin—bone cancer	3.6e-05	0.000886	CcSEcCtD
Ixabepilone—Body temperature increased—Doxorubicin—bone cancer	3.6e-05	0.000886	CcSEcCtD
Ixabepilone—Diarrhoea—Methotrexate—bone cancer	3.6e-05	0.000885	CcSEcCtD
Ixabepilone—Asthenia—Epirubicin—bone cancer	3.53e-05	0.000869	CcSEcCtD
Ixabepilone—TUBB3—Metabolism of proteins—EIF2S1—bone cancer	3.52e-05	0.000487	CbGpPWpGaD
Ixabepilone—Pruritus—Epirubicin—bone cancer	3.48e-05	0.000857	CcSEcCtD
Ixabepilone—Dizziness—Methotrexate—bone cancer	3.48e-05	0.000856	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—DHFR—bone cancer	3.43e-05	0.000475	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—EIF2S1—bone cancer	3.41e-05	0.000472	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—CHEK2—bone cancer	3.38e-05	0.000468	CbGpPWpGaD
Ixabepilone—Diarrhoea—Epirubicin—bone cancer	3.37e-05	0.000828	CcSEcCtD
Ixabepilone—Hypersensitivity—Doxorubicin—bone cancer	3.36e-05	0.000825	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle—DHFR—bone cancer	3.35e-05	0.000464	CbGpPWpGaD
Ixabepilone—Vomiting—Methotrexate—bone cancer	3.35e-05	0.000823	CcSEcCtD
Ixabepilone—TUBB1—Metabolism of proteins—EIF2S1—bone cancer	3.34e-05	0.000461	CbGpPWpGaD
Ixabepilone—Rash—Methotrexate—bone cancer	3.32e-05	0.000816	CcSEcCtD
Ixabepilone—Dermatitis—Methotrexate—bone cancer	3.31e-05	0.000815	CcSEcCtD
Ixabepilone—Headache—Methotrexate—bone cancer	3.3e-05	0.000811	CcSEcCtD
Ixabepilone—Asthenia—Doxorubicin—bone cancer	3.27e-05	0.000804	CcSEcCtD
Ixabepilone—Dizziness—Epirubicin—bone cancer	3.26e-05	0.000801	CcSEcCtD
Ixabepilone—Pruritus—Doxorubicin—bone cancer	3.22e-05	0.000793	CcSEcCtD
Ixabepilone—Vomiting—Epirubicin—bone cancer	3.13e-05	0.00077	CcSEcCtD
Ixabepilone—Nausea—Methotrexate—bone cancer	3.13e-05	0.000769	CcSEcCtD
Ixabepilone—Diarrhoea—Doxorubicin—bone cancer	3.12e-05	0.000767	CcSEcCtD
Ixabepilone—Rash—Epirubicin—bone cancer	3.1e-05	0.000763	CcSEcCtD
Ixabepilone—Dermatitis—Epirubicin—bone cancer	3.1e-05	0.000763	CcSEcCtD
Ixabepilone—Headache—Epirubicin—bone cancer	3.08e-05	0.000759	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle—DHFR—bone cancer	3.07e-05	0.000424	CbGpPWpGaD
Ixabepilone—Dizziness—Doxorubicin—bone cancer	3.01e-05	0.000741	CcSEcCtD
Ixabepilone—TUBB4A—Metabolism of proteins—EIF2S1—bone cancer	3e-05	0.000414	CbGpPWpGaD
Ixabepilone—Nausea—Epirubicin—bone cancer	2.92e-05	0.000719	CcSEcCtD
Ixabepilone—Vomiting—Doxorubicin—bone cancer	2.9e-05	0.000712	CcSEcCtD
Ixabepilone—Rash—Doxorubicin—bone cancer	2.87e-05	0.000706	CcSEcCtD
Ixabepilone—Dermatitis—Doxorubicin—bone cancer	2.87e-05	0.000706	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—BRCA2—bone cancer	2.87e-05	0.000397	CbGpPWpGaD
Ixabepilone—Headache—Doxorubicin—bone cancer	2.85e-05	0.000702	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle—CHEK2—bone cancer	2.8e-05	0.000388	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—EIF2S1—bone cancer	2.74e-05	0.000379	CbGpPWpGaD
Ixabepilone—Nausea—Doxorubicin—bone cancer	2.71e-05	0.000665	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle—CHEK2—bone cancer	2.56e-05	0.000355	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—CDK4—bone cancer	2.38e-05	0.000329	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—BRCA2—bone cancer	2.38e-05	0.000329	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—BRCA2—bone cancer	2.17e-05	0.000301	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—CDK4—bone cancer	2.13e-05	0.000294	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—RB1—bone cancer	2.07e-05	0.000286	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—CDK4—bone cancer	1.97e-05	0.000273	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—RB1—bone cancer	1.85e-05	0.000256	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—CDK4—bone cancer	1.8e-05	0.000249	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—CDK4—bone cancer	1.76e-05	0.000244	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—RB1—bone cancer	1.71e-05	0.000237	CbGpPWpGaD
Ixabepilone—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	1.61e-05	0.000223	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—CDK4—bone cancer	1.61e-05	0.000223	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—MDM2—bone cancer	1.58e-05	0.000218	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—RB1—bone cancer	1.57e-05	0.000217	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—RB1—bone cancer	1.53e-05	0.000212	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—MMP2—bone cancer	1.49e-05	0.000206	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—MMP2—bone cancer	1.49e-05	0.000206	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—MMP2—bone cancer	1.44e-05	0.000199	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—RB1—bone cancer	1.4e-05	0.000194	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—MMP2—bone cancer	1.4e-05	0.000193	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—MMP2—bone cancer	1.36e-05	0.000189	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—MDM2—bone cancer	1.31e-05	0.000181	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—MMP2—bone cancer	1.23e-05	0.000169	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—MDM2—bone cancer	1.19e-05	0.000165	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—MMP2—bone cancer	1.12e-05	0.000155	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—GSTP1—bone cancer	1.05e-05	0.000145	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	1.03e-05	0.000143	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—TP53—bone cancer	9.05e-06	0.000125	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—TP53—bone cancer	7.5e-06	0.000104	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—NDUFA12—bone cancer	7.33e-06	0.000101	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—TP53—bone cancer	6.86e-06	9.48e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—NT5C3A—bone cancer	6.07e-06	8.4e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ENO2—bone cancer	2.66e-06	3.68e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—DHFR—bone cancer	2.47e-06	3.41e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GNA11—bone cancer	2.31e-06	3.19e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GSTP1—bone cancer	1.79e-06	2.47e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PTGS2—bone cancer	9.27e-07	1.28e-05	CbGpPWpGaD
